Clinical trials: Frozen Shoulder
Frozen Shoulder
The Anti-Freaze-F Study- "Anti-TNF for Treatment of Frozen Shoulder - a Feasibility Study"
Frozen shoulder is a common condition affecting approximately 9% of people aged 25-64 years. During the early phase the pain is usually unbearable and the later restriction in movement is severely limiting.
- Trial name
- Anti-FreazeF (NCT05299242)
- Testing
- Adalimumab Injection
- Where
- 4 sites in United Kingdom
- Volunteers
- 9 people
- Sponsor
- University of Oxford
Adhesive Capsulitis, Adhesive Capsulitis of Unspecified Shoulder
Intra-articular Doxycycline: A Novel Treatment of Adhesive Capsulitis
We will recruit a total of 40 patients from the Vanderbilt Sports Medicine Clinics who have been diagnosed with adhesive capsulitis and have not undergone any previous treatment.
- Conditions
- Adhesive Capsulitis, Adhesive Capsulitis of Unspecified Shoulder, Frozen Shoulder
- Trial name
- DOXY (NCT03479502)
- Testing
- Methylprednisolone Injectable Product, Doxycycline Injection
- Where
- United States
- Volunteers
- 1 people, healthy volunteers welcome
- Sponsor
- Vanderbilt University Medical Center
Adhesive Capsulitis, Frozen Shoulder
Safety and Efficacy of EN3835 in Participants With Frozen Shoulder
This study will evaluate the safety and efficacy of EN3835 for the treatment of adhesive capsulitis of the shoulder (frozen shoulder).
- Trial name
- NCT04496167
- Testing
- EN3835
- Where
- 38 sites in United States
- Volunteers
- 198 people
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
Adhesive Capsulitis, Frozen Shoulder
AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
The objectives of this study are to assess the safety, effectiveness, and immunogenicity of AA4500 in the treatment of adhesive capsulitis.
- Trial name
- NCT01483963
- Testing
- AA4500 0.29 mg/1 mL, AA4500 0.58 mg/2 mL, AA4500 0.58 mg/1 mL
- Where
- 15 sites in United States
- Volunteers
- 50 people
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
Adhesive Capsulitis, Frozen Shoulder
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
The objectives of this study are to assess the safety, effectiveness, and immunogenicity of AA4500 in the treatment of adhesive capsulitis.
- Trial name
- AC (NCT02006719)
- Testing
- Collagenase Clostridium Histolyticum
- Where
- 46 sites in United States, Australia
- Volunteers
- 322 people
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company